Turnover: million EUR ()
Country: Austria
Dr. Schär is an international family business based in South Tyrol, which has evolved from a pioneer in the niche market to a specialist in nutritional solutions. Thanks to its research and development center in Trieste, Dr. Schär is able to innovate and offer top-quality products. With over 100 years' experience, the company develops products to meet specific nutritional needs.
The company employs 1,600 people and is present in 11 countries through its 18 production sites. It is the market leader in gluten-free nutrition, and is gaining ground in the market for nutrition to treat kidney ailments, as well as producing dietary supplements.
The brand generates sales of over €20 million in France
News
Gluten-free diet: out of fashion? 20/02/2020
- Between 2015 and 2018, sales of gluten-free products in supermarkets jumped 35% in volume terms
- In 2018, the gluten-free market grew by only 4%
- In 2019, this market was worth around €90 million in French supermarkets. By comparison, organic food purchases reached 9.7 billion euros in 2018.
- The gluten-free diet addresses the specific problems of celiac sufferers, who account for 1% of the French population, but only 10% to 20% of these people are screened.
- Dr Schär, one of the leaders in the sector, generates sales of 23 million euros in France, with a 35% market share in the dietetic section of supermarkets.
- Ekibio generates sales of 100 million euros, including 80 million in the food sector. Sales of gluten-free products total 29 million euros.
- Nature & Cie, a small brand distributed in specialized stores, generates sales of 3 million euros.
- In 2018, a 10% increase in organic gluten-free products was noted.
Financial Data
DUNS: 797390770
Legal Name: DR. SCHAR FRANCE
Address: 8 AVENUE TONY GARNIER QUATOR, 69007 LYON
Number of employees: Entre 20 et 49 salariés (2021)
Capital: 50 000 EUR
Financial Data:
| Year | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|
| Turnover | 21 062 426 | 19 841 378 | 20 898 758 | 2 638 446 | 2 417 164 |
| Gross margin (€) | 10 528 251 | 9 457 990 | 9 676 001 | 904 392 | 849 088 |
| EBITDA (€) | -368 791 | 1 660 387 | 2 426 200 | -323 649 | 536 074 |
| Operating profit (€) | -332 135 | 1 605 517 | 2 419 018 | -339 680 | 534 861 |
| Net profit (€) | -431 875 | 961 545 | 1 596 072 | -227 595 | 356 946 |
| Turnover growth rate (%) | 6,2 | -5,1 | 692,1 | 9,2 | - |
| Ebitda margin rate (%) | -1,8 | 8,4 | 11,6 | -12,3 | 22,2 |
| Operating margin rate (%) | -1,6 | 8,1 | 11,6 | -12,9 | 22,1 |
| Working Capital (turnover days) | 2,5 | 9,8 | -5,1 | 16,3 | -7,6 |
| Working Capital requirements (turnover days) | 4,8 | 5 | 7,5 | -6,8 | 2,1 |
| Net margin (%) | -2,1 | 4,8 | 7,6 | -8,6 | 14,8 |
| Added value / Turnover (%) | 6 | 15 | 16,8 | 7,1 | 23,8 |
| Wages and social charges (€) | 1 563 920 | 1 259 023 | 1 009 332 | 503 459 | 35 595 |
| Salaries / Turnover (%) | 7,4 | 6,3 | 4,8 | 19,1 | 1,5 |
Company Managers:
| Position | First Name | Last Name | Age | |
|---|---|---|---|---|
| Président | Werner | Strobl | 58 | |
| Commissaire aux comptes suppléant | Raoul | Poinsignon | 64 |
Studies mentioning this company
The gluten-free food market - France
Other companies mentioned:
- Nutrition & Santé Groupe
- ABCD Nutrition
- Dr Schär
- La Vie Claire
- Biscuiterie de Provence
- Ekibio (Groupe Lea Biodiversité)
- Bio c' Bon
- Allergoora
- Nature & Cie
- Barilla
- Aglina Paradeigma
- Soreda Diet - BioRévola
- Céliane
- Genius Gluten Free
- Jardin Bio (Léa Nature)
- Le Pain des Fleurs
- Ekibio - Ma Vie Sans Gluten
- Max de Génie
- No Gluten Pro - Allergonline
- Noglu
- Valpiform - Nutrition et Santé groupe
- Paradeigma
The gluten-free food market - Portugal
Other companies mentioned:
- Dr Schär
- Pingo Doce
- Continente
- Alpro (Promavel)
- Nutriben (Alter Pharmacia)